Papers
1
Total Citations
37
H-Index
1
About
Dr. Liwei Zhu is pioneering the frontier of cancer theranostics through innovative bionic systems and aggregation-induced emission (AIE) materials. His research focuses on developing multimodal phototheranostic platforms that integrate photodynamic, photothermal, and immunotherapeutic mechanisms into single, highly efficient agents. Dr. Zhu’s most notable contribution is the creation of an AIE luminogen-bacteria hybrid bionic robot, which leverages living bacteria as a delivery vehicle for precise tumor targeting and synergistic therapy. This groundbreaking work, published in 2025 and already garnering 37 citations, overcomes the limitations of conventional photosensitizers by combining multiple photosensitizing mechanisms within one system, enabling a "one-and-done" approach to cancer treatment. By merging materials science with synthetic biology, Dr. Zhu’s research offers a powerful new strategy for enhancing therapeutic efficacy while minimizing side effects. His work stands at the intersection of nanotechnology, immunotherapy, and bioengineering, promising to transform how we design next-generation cancer therapies.
Research Focus
Key Achievements
Top Papers
- 1